Although this study was originally grounded on the rationale that MIF/CD74 axis drives poor immunogenicity in metastatic melanoma, a significant limitation of this study is the lack of functional validation for the hypoxia-related results in MIF/CD74 dependent signalling. Here, MIF is linked to metastatic melanoma.